Search Results - "Vilmer, E"

Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy by DE BOTTON, S, COITEUX, V, ROBERT, A, J. SAN MIGUEL, CONDE, E, SOTTO, J. J, BORDESSOULE, D, FEGUEUX, N, FEY, M, PARRY, A, CHOMIENNE, C, DEGOS, L, CHEVRET, S, FENAUX, P, RAYON, C, VILMER, E, SANZ, M, DE LA SERNA, J, PHILIPPE, N, BORUCHEL, A, LEVERGER, G

“…To determine the results of treatment combining all-trans-retinoic acid (ATRA) and chemotherapy (CT) in childhood acute promyelocytic leukemia (APL). Children…”
Get full text

Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study by Steffen, C, Auclerc, M F, Auvrignon, A, Baruchel, A, Kebaili, K, Lambilliotte, A, Leverger, G, Sommelet, D, Vilmer, E, Hémon, D, Clavel, J

“…Aim: To analyse the association between potential environmental exposure to hydrocarbons and the risk of acute childhood leukaemia. Methods: A hospital based…”
Get full text

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia : a CLCG-EORTC report by VILMER, E, SUCIU, S, MANEL, A.-M, ROBERT, A, NELKEN, B, MILLOT, F, LUTZ, P, RIALLAND, X, MECHINAUD, F, BOUTARD, P, BEHAR, C, CHANTRAINE, J-M, FERSTER, A, PLOUVIER, E, LAUREYS, G, BROCK, P, UYTTEBROECK, A, MARGUERITTE, G, PLANTAZ, D, NORTON, L, FRANCOTTE, N, GYSELINCK, J, WATERKEYN, C, BERTRAND, Y, SOLBU, G, PHILIPPE, N, OTTEN, J, CAVE, H, THYSS, A, BENOIT, Y, DASTUGUE, N, FOURNIER, M, SOUILLET, G

“…We present here the long-term results of three randomized clinical trials conducted on children with newly diagnosed acute lymphoblastic leukemia (ALL) between…”
Get full text

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements by PUI, C-H, CHESSELLS, J. M, HARHOTT, J, HARMS, D. O, HARRISON, C. J, HARRISON, P. L, HEEREMA, N, JANKA-SCHAUB, G, KAMPS, W, MASERA, G, PULLEN, J, RAIMONDI, S. C, CAMITTA, B, RICHARDS, S, RIEHM, H, SALLAN, S, SATHER, H, SHUSTER, J, SILVERMAN, L. B, VALSECCHI, M. G, VILMER, E, ZHOU, Y, GAYNON, P. S, BARUCHEL, A, SCHRAPPE, M, BIONDI, A, BOYETT, J. M, CARROLL, A, EDEN, O. B, EVANS, W. E, GADNER, H

“…To assess the clinical heterogeneity among patients with acute lymphoblastic leukemia (ALL) and various 11q23 abnormalities, we analyzed data on 497 infants,…”
Get full text

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia by BERGER, C, LE-GALLO, B, MICHEL, G, STEPHAN, J. L, DONADIEU, J, RICHARD, O, DEVERGIE, A, GALAMBRUN, C, BORDIGONI, P, VILMER, E, PLOUVIER, E, PEREL, Y

“…The purpose of this study was to identify risk factors for hypothyroidism after bone marrow transplantation (BMT) for high-risk or relapsed acute lymphoblastic…”
Get full text

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children by LEGRAND, F, BERREBI, D, HOUHOU, N, FREYMUTH, F, FAYE, A, DUVAL, M, MOUGENOT, J. F, PEUCHMAUR, M, VILMER, E

“…Adenovirus infection remains an important cause of mortality after bone marrow transplantation (BMT). Currently no efficient antiviral treatment is known…”
Get full text

Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study by PERRILLAT, F, CLAVEL, J, HEMON, D, AUCLERC, M. F, BARUCHEL, A, LEVERGER, G, NELKEN, B, PHILIPPE, N, SCHAISON, G, SOMMELET, D, VILMER, E

“…We conducted a case-control study to investigate the role of early infections in the aetiology of childhood acute leukaemias. The study included 280 incident…”
Get full text

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report by Entz-Werle, N, Suciu, S, van der Werff ten Bosch, J, Vilmer, E, Bertrand, Y, Benoit, Y, Margueritte, G, Plouvier, E, Boutard, P, Vandecruys, E, Ferster, A, Lutz, P, Uyttebroeck, A, Hoyoux, C, Thyss, A, Rialland, X, Norton, L, Pages, M-P, Philippe, N, Otten, J, Behar, C

“…The first EORTC (European Organization of Research and Treatment of Cancer) acute myeloblastic leukemia (AML) pilot study (58872) was conducted between January…”
Get full text

Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? by Fakhoury, M., Andreu-Gallien, J., Mahr, A., Medard, Y., Azougagh, S., Vilmer, E., Jacqz-Aigrain, E.

“…Summary Background and objective:  The activity of thiopurine S‐methyltransferase (TPMT), a key enzyme in the metabolism of purine analogues, displays wide…”
Get full text

Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999 by Clavel, J, Goubin, A, Auclerc, M F, Auvrignon, A, Waterkeyn, C, Patte, C, Baruchel, A, Leverger, G, Nelken, B, Philippe, N, Sommelet, D, Vilmer, E, Bellec, S, Perrillat-Menegaux, F, Hémon, D

“…The French National Registry of Childhood Leukaemia and Lymphoma (NRCL) covers the whole French mainland population aged less than 15 years (approximately 11…”
Get full text

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia by Yotnda, P, Garcia, F, Peuchmaur, M, Grandchamp, B, Duval, M, Lemonnier, F, Vilmer, E, Langlade-Demoyen, P

“…Cytotoxic T lymphocytes (CTL) are potent effector cells that could provide long term antitumor immunity if induced by appropriate vaccines. CTL recognize 8-14…”
Get full text

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM) by MICHALLET, M, TANGUY, M. L, DEMEOCQ, F, JOUET, J. P, MICHALLET, A. S, IFRAH, N, VILMER, E, MOLINA, L, MICHEL, G, LIOURE, B, CAVAZZANA-CALVO, M, PICO, J. L, SOCIE, G, SADOUN, A, GUYOTAT, D, ATTAL, M, CURE, H, BORDIGONI, P, SUTTON, L, BUZYN-VEIL, A, TILLY, M, LEPORRIER, M, FEGUEUX, N, THIEBAUT, A, DREYFUS, F, RIO, B, LUTZ, P, VERNANT, J. P, BELHABRI, A, MILPIED, N, REIFFERS, J, KUENTZ, M, CAHN, J. Y, BLAISE, D

“…Although recurrent malignancy is the most frequent indication for second stem cell transplantation (2nd SCT), there are few reports that include sufficiently…”
Get full text

Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group by AKKARI, V, DONADIEU, J, BERTRAND, Y, PIGUET, C, BORDIGONI, P, MICHEL, G, BLANCHE, S, CASANOVA, J. L, THOMAS, C, VILMER, E, FISCHER, A

“…The aim of this study was to assess the results of hematopoietic stem cell transplantation (HSCT) in refractory Langerhans cell histiocytosis (LCH). Among 85…”
Get full text

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura by Debré, M, Bonnet, M C, Fridman, W H, Carosella, E, Philippe, N, Reinert, P, Vilmer, E, Kaplan, C, Teillaud, J L, Griscelli, C

“…Treatment of acute immune thrombocytopenic purpura (ITP) with intravenous immunoglobulin (IVIG) induces partial or complete responses, shown by transient or…”
Get more information

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders by Faye, A, Van Den Abeele, T, Peuchmaur, M, Mathieu-Boue, A, Vilmer, E

“…Faye et al report a 13-year-old boy with Fanconi disease transplanted with a non-T-depleted graft from a matched unrelated donor. The boy was given Anti-CD20…”
Get full text

Listing of Common HLA Alleles and Haplotypes Based on the Study of 356 Families Residing in the Paris, France, Area: Implications for Unrelated Hematopoietic Stem Cell Donor Selection by Pedron, B., Yakouben, K., Adjaoud, D., Auvrignon, A., Landman, J., Guerin, V., Leverger, G., Vilmer, E., Sterkers, G.

“…In this study we have identified frequent human leukocyte antigen (HLA)-A, -B, -C,-DRB1, and -DQB1 alleles, frequent HLA-B/C, HLA-DRB1/DQB1 two-allele…”
Get full text

Value of High-Dose Cytarabine During Interval Therapy of a Berlin-Frankfurt-Munster–Based Protocol in Increased-Risk Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial by MILLOT, F, SUCIU, S, MARGUERITE, G, FERSTER, A, PLOUVIER, E, RIALLAND, X, BEHARD, C, PLANTAZ, D, DRESSE, M. F, PHILIPPET, P, NORTON, L, THYSS, A, PHILIPPE, N, DASTUGUE, N, WATERKEYN, C, VILMER, E, OTTEN, J, BENOIT, Y, MAZINGUE, F, UYTTEBROECK, A, LUTZ, P, MECHINAUD, F, ROBERT, A, BOUTARD, P

“…The European Organization for Research and Treatment of Cancer 58881 study was designed to test in a prospective multicentric randomized trial the value of…”
Get full text

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG by VAN DER WERFF TEN BOSCH, J, SUCIU, S, FERSTER, A, PLOUVIER, E, MAES, P, MUNZER, M, PLANTAZ, D, DRESSE, M.-F, PHILIPPET, P, SIRVENT, N, WATERKEYN, C, VILMER, E, THYSS, A, PHILIPPE, N, OTTEN, J, BERTRAND, Y, NORTON, L, MAZINGUE, F, UYTTEBROECK, A, LUTZ, P, ROBERT, A, BOUTARD, P

“…Between November 1990 and November 1996, EORTC Children Leukemia Group conducted a randomized trial in de novo acute lymphoblastic leukemia and lymphoblastic…”
Get full text

Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine by DERVIEUX, T, MEDARD, Y, VERPILLAT, P, GUIGONIS, V, DUVAL, M, LESCOEUR, B, SUCIU, S, VILMER, E, JACQZ-AIGRAIN, E

“…6-Mercaptopurine (6-MP) is metabolized by thiopurine S-methyltransferase (TPMT), an enzyme subject to genetic polymorphism. We investigated the relationships…”
Get full text

Incidence, severity, and prevention of infections in chronic granulomatous disease by Mouy, R, Fischer, A, Vilmer, E, Seger, R, Griscelli, C

“…We retrospectively analyzed the frequency and nature of infections occurring in 48 patients with chronic granulomatous disease. The long-term use of…”
Get more information